| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.45 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |